Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Learn effective ways to cash in fast with quick strategies for extra cash. These methods can help you achieve financial flexibility.
20,514 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A FormFactor director recently sold 3,000 shares in a move that drew attention from investors. This article breaks do...
BluePeak Capital disclosed it sold additional common shares to fund a $40 million bitcoin purchase, even as its total...
Tariffs are a powerful tool, but can they really replace the income tax? This analysis dives into the economics, data...
Trade Desk beat Q4 expectations but issued softer Q1 guidance, sparking a swift market reaction as investors weigh sl...
Warner Bros. Discovery has ruled Paramount's bid superior, setting a tight four-day window for Netflix to respond as ...
A wave of AI anxiety moved from online whispers to market headlines this week, forcing households to rethink budgets,...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...
A major fund reported a sizeable exit from an offshore energy stake, triggering a review of how investors manage risk...
Markets swing as geopolitical tensions flare between the U.S. and Iran. This analysis traces the past CIA plan and ex...
Artemis II tightens the horizon for space infrastructure spending as major primes and component makers post strong ba...
The YieldMax TSLA Option Income Strategy ETF drew attention in 2024 for big payouts and a high-yield claim, but its s...